Personal Wheezometer™ ישראל - עברית - Ministry of Health

personal wheezometer™

כרמלסוניקס ישראל - כלל האוכלוסיה

Extension Tubes for Infusion ישראל - עברית - Ministry of Health

extension tubes for infusion

טבע מדיקל (שיווק) בע"מ - כלל האוכלוסיה - צינורות להארכת סטים לעירוי

סבון ידיים סיוון- JOHNSON DIVERSEY ישראל - עברית - Ministry of Health

סבון ידיים סיוון- johnson diversey

א.ל. ארמן יצור תמרוקים בעמ - רחצת הגוף

אסיול 10 מג2 מל ישראל - עברית - Ministry of Health

אסיול 10 מג2 מל

teva pharmaceutical industries ltd, israel - diazepam - תמיסה להזרקה - diazepam 10 mg / 2 ml - diazepam - diazepam - symptomatic relief of tension and anxiety either alone or when associated with stressful situations. psychoneurotic states manifested by tension, anxiety, apprehension, fatigue and depressive symptoms. in acute alcohol withdrawal, assival may be useful in the symptomatic relief of tremor, impending or acute delirium tremens and hallucinosis. assival is a useful adjunct in the relief of skeletal muscle spasm, spasticity, stiffman syndrome and tetanus. when used intravenously, assival injection is a useful adjunct in status epilepticus and severe recurrent convulsive seizures. as premedication in patients undergoing surgical procedures (the intramuscular route is preferred) or in patients undergoing cardioversion (when the intravenous route is preferred).

אופטלגין זריקות ישראל - עברית - Ministry of Health

אופטלגין זריקות

teva pharmaceutical indust.ltd - dipyrone 1 g / 2 ml - solution for injection - metamizole sodium - as an analgesic: optalgin injection, by intravenous administration, is indicated for the relief of severe and acute pain when oral treatment is not feasible or suitable, as in post-traumatic or post-surgical pain, biliary or renal colic, and pain associated with malignant diseases. intravenous administration of dipyrone should be carried out slowly over a period of at least 5 minutes, followed by reasonable clinical observation. intramuscular administration of dipyrone for relief of pain is not recommended.however, if medical circumstances require such administration, all due precautions should be exercised to permit reasonable clinical observation. as an antipyretic: optalgin injection by intramuscular administration is indicated to lower temperature in life-threatening situations, when this cannot be achieved by other means. hyperthermic patients in critical condition may also be treated in non-hospital environment, under close medical supervision.

פלומיסט קואדריוואלנט ישראל - עברית - Ministry of Health

פלומיסט קואדריוואלנט

astrazeneca (israel) ltd - a/darwin/9/2021 (h3n2)-like virus; a/victoria/4897/2022 (h1n1)pdm09-like virus; b/austria/1359417/2021 (b/victoria lineage)-like virus; b/phuket/3073/2013 (b/yamagata lineage)-like virus - ספריי לאף - b/phuket/3073/2013 (b/yamagata lineage)-like virus 7 ±0.5 log10 ffu^a / 0.2 ml; a/darwin/9/2021 (h3n2)-like virus 7 ±0.5 log10 ffu^a / 0.2 ml; b/austria/1359417/2021 (b/victoria lineage)-like virus 7 ±0.5 log10 ffu^a / 0.2 ml; a/victoria/4897/2022 (h1n1)pdm09-like virus 7 ±0.5 log10 ffu^a / 0.2 ml - influenza, inactivated, split virus or surface antigen - influenza, purified antigen - flumist quadrivalent is a vaccine indicated for active immunization for the prevention of influenza disease caused by influenza a subtype viruses ad type b viruses contained in the vaccine. flumist quadrivalent is approved for use in persons 2 through 49 years of age.

ארומזין ישראל - עברית - Ministry of Health

ארומזין

pfizer pfe pharmaceuticals israel ltd - exemestane - טבליות מצופות - exemestane 25 mg - exemestane - exemestane - aromasin is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. aromasin is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies. aromasin is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.